Skip to main content
PMC home page
Wiley - PMC COVID-19 Collection logoLink to Wiley - PMC COVID-19 Collection
. 2005 Nov 22;15(3):267–274. doi: 10.1002/art.1780150308

Virus antibody levels in systemic lupus erythematosus

Eric R Hurd 1,✉, Walter Dowdle 2, Helen Casey 3, Morris Ziff 4
PMCID: PMC7159734  PMID: 4338011

Abstract

Antibody titers to a group of viral antigens have been determined in sera from patients with systemic lupus erythematosus (SLE), control groups with inflammatory diseases and normals. Mean titers in SLE sera for all viruses tested were significantly greater than in four control groups, but not greater than in active tuberculosis, both by the complement‐fixation (CF) and hemagglutination‐inhibition (HI) methods. By the CF method, only measles virus showed significantly higher titers in SLE than in all control groups; by the HI method, measles antibody titers were higher in SLE than in all groups but tuberculosis. There was no correlation between antibody titers and gammaglobulin levels. The results indicated a moderate though variable overall hypereactivity in SLE to the viral antigens tested.

References

  • 1. Fresco R: Tubular (myxovirus‐like) structures in glomerular deposits from a case of lupus nephritis. Fed Proc 27: 246, 1968. [Google Scholar]
  • 2. Gyorkey F, Sinkovics JG, Min KW, et al: Systemic lupus erythematosus and myxovirus (correspondence). N Engl J Med 280: 333–336, 1969. [DOI] [PubMed] [Google Scholar]
  • 3. Hurd ER, Eigenbrodt E, Ziff M, et al: Cytoplasmic tubular structures in kidney biopsies in systemic lupus erythematosus. Arthritis Rheum 12: 541–542, 1969. [DOI] [PubMed] [Google Scholar]
  • 4. Norton WL: Endothelial inclusions in active lesions of systemic lupus erythematosus. J Lab Clin Med 74: 369–379, 1969. [PubMed] [Google Scholar]
  • 5. Haas, YE , Yunis EJ: Tubular inclusions of systemic lupus erythematosus. Ultrastructural observations regarding their possible viral nature. Exp Mol Pathol 12: 257–263, 1970. [Google Scholar]
  • 6. Herndon RM, Rubinstein LJ: Light and electron microscopic observation on the development of viral inclusions of Dawson's encephalitis (subacute sclerosing panencephalitis). Neurology 18: 8–20, 1968. [DOI] [PubMed] [Google Scholar]
  • 7. Dayan AD, Gostling JVT, Greaves JL, et al: Evidence of a pseudomyxovirus in the brain in subacute sclerosing leucoencephalitis. Lancet 1: 980–981, 1967. [DOI] [PubMed] [Google Scholar]
  • 8. Freeman JM, Magoffin RL, Lennette EH, et al: Additional evidence of the relation between subacute inclusion‐body encephalitis and measles virus. Lancet 2: 129–131, 1967. [DOI] [PubMed] [Google Scholar]
  • 9. Shaw C‐M, Buchan GC Carlson CB: Myxovirus as a possible etiologic agent in subacute inclusion‐body encephalitis. N Engl J Med 277: 511–515, 1967. [DOI] [PubMed] [Google Scholar]
  • 10. Connolly JH, Allen IV, Hurwitz LJ, et al: Measles virus antibody and antigen in subacute sclerosing panencephalitis. Lancet 1: 542–544, 1967. [DOI] [PubMed] [Google Scholar]
  • 11. Legg NJ: Virus antibodies in subacute sclerosing panencephalitis: study of 22 patients. Br Med J 3: 350–352, 1967. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12. Zeman W, Kolar O: Reflections on the etiology and pathogenesis of subacute sclerosing panencephalitis. Neurology 18: 1–7, 1968. [DOI] [PubMed] [Google Scholar]
  • 13. Payne FE, Baublis JV, Itabashi HH: Isolation of measles virus from cell cultures of brain from a patient with subacute sclerosing panencephalitis. N Engl J Med 281: 585–589, 1969. [DOI] [PubMed] [Google Scholar]
  • 14. Chen TT, Watanabe I, Zeman W: Subacute sclerosing panencephalitis: propagation of measles virus from brain biopsy in tissue culture. Science 163: 1193–1194, 1969. [DOI] [PubMed] [Google Scholar]
  • 15. Katz M, Oyanagi S, Koprowski H: Subacute sclerosing panencephalitis: structures resembling myxovirus nucleocapsids in cells cultured from brains. Nature 222: 888–890, 1969. [DOI] [PubMed] [Google Scholar]
  • 16. Horta‐Barbosa L, Fucillo DA, Sever JL, et al: Subacute sclerosing panencephalitis: isolation of measles virus from a brain biopsy. Nature 221: 974–978, 1969. [DOI] [PubMed] [Google Scholar]
  • 17. Horne RW, Waterson AP, Wildy P, et al: The structure and composition of the myxovirus. 1. Electron microscope studies of the structure of myxovirus particles by negative staining techniques. Virology 11: 79–98, 1960. [DOI] [PubMed] [Google Scholar]
  • 18. Duc‐Nguyen H, Rosenblum EN: Immunoelectron microscopy of the morphogenesis of mumps virus. J Virol 1: 415, 1967. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19. Doane FW, Anderson N, Chatiyanonda K, et al: Rapid laboratory diagnosis of paramyxovirus infections by electron microscopy. Lancet 2: 751–753, 1967. [Google Scholar]
  • 20. Phillips PE, Christian CL: Myxovirus antibody increases in human connective tissue disease. Science 168: 982–984, 1970. [DOI] [PubMed] [Google Scholar]
  • 21. Evans AS, Rothfield NF, Niederman JC: Raised antibody titers to EB virus in systemic lupus erythematosus. Lancet 1: 167–168, 1971. [DOI] [PubMed] [Google Scholar]
  • 22. Hollinger FB, Sharp JT, Lidsky MD, et al: Antibodies to viral antigens in systemic lupus erythematosus. Arthritis Rheum 14: 1–11, 1971. [DOI] [PubMed] [Google Scholar]
  • 23. Hurd ER, Dowdle W, Casey H, et al: Virus antibody levels in systemic lupus erythematosus. Arthritis Rheum 13: 324, 1970. (Abstr) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24. Casey HL, Kokko UP, Schubert JH, et al: Standardized diagnostic complement fixation method and adaptation to micro test. Public Health Monograph No. 74, United States Department of Health, Education and Welfare, United States Public Health Service, Washington, DC: [Google Scholar]
  • 25. Viral and Rickettsial infections. Edited by Lennette HE. and Schmidt NJ. Fourth edition American Public Health Association, 1969. [Google Scholar]
  • 26. Armitage P: In Statistical Methods in Medical Research. Sections 13.2, 13.3, 4.4 and 4.8. New York, John Wiley and Sons, 1972. [Google Scholar]
  • 27. Kendall MG, Stuart A: In The Advanced Theory of Statistics. Vol 2, Section 31.19. New York, Hafner Publishing Company, Inc., 1967. [Google Scholar]
  • 28. Lindquist KJ, Coleman RE, Osterland CK: Autoantibodies in chronic pulmonary tuberculosis. J Chronic Dis 22: 717–725, 1970. [DOI] [PubMed] [Google Scholar]
  • 29. Morton JI, Siegel BV: Development of Coombs positive haemolytic anaemia in NZB mice injected with Freund's Complete Adjuvant. Immunology 18: 379–386, 1970. [PMC free article] [PubMed] [Google Scholar]
  • 30. Abe T, Homma M: Immunological reactivity in patients with systemic lupus erythematosus. Acta Rheumatol Scand 17: 35–46, 1971. [DOI] [PubMed] [Google Scholar]
  • 31. Block SR, Gibbs, CB , Stevens MB, et al: Delayed Hypersensitivity in systemic lupus erythematosus. Ann Rheum Dis 27: 311–318, 1968. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32. Bitter T, Bitter F, Silberschmidt R, et al: In vivo and in vitro study of cell‐mediated immunity during the onset of systemic lupus erythematosus. Arthritis Rheum 14: 152–153, 1971. (Abstr) [Google Scholar]
  • 33. Teague PO, Yunis EJ, Rodey G, et al: Autoimmune phenomena and renal disease in mice. Role of thymectomy, aging and involution of immunologic capacity. Lab Invest 22: 121–130, 1970. [PubMed] [Google Scholar]
  • 34. Leventhal BG, Talal N: Response of NZB and NZB/NZW spleen cells to mitogenic agents. J Immunol 104: 918–923, 1970. [PubMed] [Google Scholar]
  • 35. Tonietti G, Dixon FJ, Oldstone MBA: The effect of induced chronic viral infection on the immunologic diseases of New Zealand mice. J Exp Med 132: 89–109, 1970. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36. Kaplan ME: Cryoglobulinemia in infectious mononucleosis. J Lab Clin Med 71: 754–765, 1968. [PubMed] [Google Scholar]
  • 37. Kaplan ME, Tan EM: Antinuclear antibodies in infectious mononucleosis. Lancet 1: 561–563, 1968. [DOI] [PubMed] [Google Scholar]
  • 38. Kantor GL, Goldberg LS, Johnson BL, et al: Immunologic abnormalities induced by postperfusion cytomegalovirus infection. Ann Intern Med 73: 553–558, 1970. [DOI] [PubMed] [Google Scholar]
  • 39. Howard RJ, Mergenhagen SE, Notkins AL et al: Inhibition of cellular immunity and enhancement of humoral antibody formation in mice infected with lactic dehydrogenase virus. Trans Proc 1: 586–588, 1969. [PubMed] [Google Scholar]
  • 40. Koffler D, Carr RI, Agnello V, et al: Antibodies to polynucleotides in human sera: antigenic specificity and relation to disease. J Exp Med 134: 294–312, 1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41. Schur PH, Monroe M: Antibodies to ribonucleic acid in systemic lupus erythematosus. Proc Natl Acad Sci USA 63: 1108–1112, 1969. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42. Grumet FC, Coukell A, Bodmer JG, et al: Histocompatibility antigens associated with systemic lupus erythematosus. N Engl J Med 285: 193–196, 1971. [DOI] [PubMed] [Google Scholar]
  • 43. Steinberg AD, Baron S, Talal N: The pathogenesis of autoimmunity in New Zealand mice. I. Induction of antinucleic acid antibodies by polyinosinic‐polycytidylic acid. Proc Natl Acad Sci USA, 63: 1102–1107, 1969. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44. Steinberg AD, Daley GG, Talal N: Tolerance to polyinosinic‐polycytidylic acid in NZB/NZW mice. Science 167: 870–871, 1970. [DOI] [PubMed] [Google Scholar]
  • 45. Cerottini J‐C, Lambert P‐H, Dixon FJ: Comparison of the immune responsiveness of NZB and NZB X NZW F1 hybrid mice with that of other strains of mice. J Exp Med 130: 1093–1105, 1969. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46. Waller M, Sever J, Curry N, et al: Relationship between anti‐viral antibodies and rheumatoid factor in pregnant women. Ann Rheum Dis 25: 327–331, 1966. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Arthritis and Rheumatism are provided here courtesy of Wiley

RESOURCES